These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Neuromuscular and cardiovascular effects of pipecuronium. Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636 [TBL] [Abstract][Full Text] [Related]
6. Clinical experiences with pipecuronium bromide. Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488 [TBL] [Abstract][Full Text] [Related]
7. Comparative potency of pipecuronium bromide and pancuronium bromide. Stanley JC; Mirakhur RK Br J Anaesth; 1989 Dec; 63(6):754-5. PubMed ID: 2558699 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and disposition of pipecuronium bromide in the cat. Agoston S; Vandenbrom RH; Wierda JM; Houwertjes MC; Kersten UW Eur J Anaesthesiol; 1988 Jul; 5(4):233-42. PubMed ID: 2848702 [TBL] [Abstract][Full Text] [Related]
9. The influence of renal failure on the pharmacokinetics and duration of action of pipecuronium bromide in patients anesthetized with halothane and nitrous oxide. Caldwell JE; Canfell PC; Castagnoli KP; Lynam DP; Fahey MR; Fisher DM; Miller RD Anesthesiology; 1989 Jan; 70(1):7-12. PubMed ID: 2536254 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia. Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects]. Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and disposition of pipecuronium bromide in dogs with and without ligated renal pedicles. Khuenl-Brady KS; Sharma M; Chung K; Miller RD; Agoston S; Caldwell JE Anesthesiology; 1989 Dec; 71(6):919-22. PubMed ID: 2556065 [TBL] [Abstract][Full Text] [Related]
13. Neuromuscular effects of pipecuronium bromide. Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856 [TBL] [Abstract][Full Text] [Related]
14. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use. Mirakhur RK Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013 [TBL] [Abstract][Full Text] [Related]
15. A dose-response evaluation of pipecuronium bromide in elderly patients under balanced anesthesia. Azad SS; Larijani GE; Goldberg ME; Beach CA; Marr AT; Seltzer JL J Clin Pharmacol; 1989 Jul; 29(7):657-9. PubMed ID: 2547848 [TBL] [Abstract][Full Text] [Related]
16. Effects of succinylcholine on the pharmacodynamics of pipecuronium and pancuronium. Dubois MY; Fleming NW; Lea DE Anesth Analg; 1991 Mar; 72(3):364-8. PubMed ID: 1847278 [TBL] [Abstract][Full Text] [Related]